Shame proneness is associated with individual differences in temporal pole white matter structure.

Shame proneness regional white matter density right inferior temporal pole voxel-based morphometry

Journal

Social neuroscience
ISSN: 1747-0927
Titre abrégé: Soc Neurosci
Pays: England
ID NLM: 101279009

Informations de publication

Date de publication:
04 2022
Historique:
pubmed: 9 2 2022
medline: 13 4 2022
entrez: 8 2 2022
Statut: ppublish

Résumé

Shame and guilt are distinct negative moral emotions, although they are usually regarded as overlapping affective experiences. Of these two emotions, shame is more closely related to concerns about other people's judgment, whereas guilt is more related to concerns about one's own judgment. Although some studies have tried to identify the psychological process underlying shame as opposed to guilt, there is no clear evidence of brain regions that are specifically relevant to the experience of shame rather than guilt and, more generally, self-blame. We therefore investigated associations between individual differences in shame- and guilt-proneness and the gray and white matter structures of the brain using magnetic resonance imaging and voxel-based morphometry while controlling for associations with guilt- or shame-proneness. To accomplish this goal, we enrolled 590 healthy, right-handed individuals (338 men and 252 women; age, 20.6 ± 1.8 years). We administered a questionnaire to assess shame proneness and guilt proneness. Based on our hypothesis, we found that high shame proneness was associated with decreased regional white matter density only in the right inferior temporal pole, whereas no significant region was associated with guilt. The function of this area may be important for the underlying processes differentiating shame from guilt.

Identifiants

pubmed: 35130823
doi: 10.1080/17470919.2022.2039287
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

117-126

Auteurs

Carlos Makoto Miyauchi (CM)

Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Hikaru Takeuchi (H)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Yasuyuki Taki (Y)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Division of Medical Neuroimaging Analysis, Department of Community Medical Supports, Tohoku Medical Megabank Organization, Tohoku University, Sendai, Japan.
Department of Radiology and Nuclear Medicine, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Seishu Nakagawa (S)

Department of Human Brain Science, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Division of Psychiatry, Tohoku Medical and Pharmaceutical University, Sendai, Japan.

Sugiko Hanawa (S)

Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Atsushi Sekiguchi (A)

Department of Behavioral Medicine, National Institute of Mental Health, National Center of Neurology and Psychiatry, Tokyo, Japan.

Rui Nouchi (R)

Creative Interdisciplinary Research Division, Frontier Research Institute for Interdisciplinary Science, Tohoku University, Sendai, Japan.
Human and Social Response Research Division, International Research Institute of Disaster Science, Tohoku University, Sendai, Japan.
Smart Aging International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Yuko Sassa (Y)

Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Ryuta Kawashima (R)

Department of Functional Brain Imaging, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Division of Developmental Cognitive Neuroscience, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.
Smart Aging International Research Center, Institute of Development, Aging and Cancer, Tohoku University, Sendai, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH